Comparative analysis of the intestinal microbiota in patients with exocrine pancreatic insufficiency of various severity

被引:1
|
作者
Maev, Igor V. [1 ]
Levchenko, Anna I. [1 ]
Galeeva, Julia S. [2 ]
Andreev, Dmitry N. [1 ]
Osipenko, Julia V. [3 ]
Bordin, Dmitry S. [1 ,3 ,4 ]
Ilyina, Elena N. [2 ]
机构
[1] Yevdokimov Moscow State Univ Med & Dent, Moscow, Russia
[2] Res Inst Syst Biol & Med, Moscow, Russia
[3] Loginov Moscow Clin Sci Ctr, Moscow, Russia
[4] Tver State Med Univ, Tver, Russia
关键词
chronic pancreatitis; exocrine pancreatic insufficiency; intestinal microbiota; 16S rRNA; GUT MICROBIOTA;
D O I
10.26442/00403660.2023.02.202056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Exocrine pancreatic insufficiency (EPI) is a critical host factor in determining the composition of the gut microbiota. Diseases that cause exocrine insufficiency can affect the gut microbiome, which can potentiate disease progression and complications. To date, the relationship of exocrine insufficiency in various pancreatic (PA) pathologies, in chronic pancreatitis (CP), with dysbiotic changes in the intestinal microbiota (IM) has not been reliably studied. The available data are heterogeneous and contradictory, which determines the need for further research. Aim. To conduct a comparative analysis of the taxonomic composition of the intestinal microbiota in patients with CP of various etiologies, without or with the presence of EPI of varying severity, as well as patients with severe EPI with a history of surgical intervention (SI) on the pancreas. Materials and methods. A total of 85 patients were included in the study. Patients were divided into groups according to the severity of EPI: Group 1 (n=16) - patients with CP without EPI; Group 2 (n=11) - patients with CP and mild EPI; Group 3 (n=17) - patients with severe CP and EPI; Group 4 (n=41) - severe EPI in persons with a history of SI on the pancreas. Verification of CP was carried out according to clinical, anamnestic and instrumental data. The degree of EPI was determined by the level of pancreatic elastase-1 (PE-1) feces. Informed consent for the study was obtained for each patient, an anamnesis was collected, physical and laboratory examinations were performed, and a stool sample was obtained. DNA was extracted from each stool sample, the taxonomic composition of BM was determined by sequencing the bacterial 16S rRNA genes, followed by bioinformatic analysis. Results. We followed the changes in the gut microbiota from a group of patients with CP without EPI to a group with severe EPI, in those who underwent SI. At the level of the phylum, the IM of all groups showed the dominance of Firmicutes, with the lowest representation in the severe EPI group, both with SI and CP, and the growth of the Actinobacteria, Verrucomicrobiota and Fusobacteria types. The differential representation of childbirth varied: in patients with severe EPI and CP, compared with mild, statistically significant genera - Akkermansia, Ruminococcus gauvreauii group and Holdemanella; compared with CP without exocrine insufficiency, Prevotella, Ruminococcus gauvreauii group, Peptostreptococcus and Blautia dominated. The CP group with mild EPI was dominated by the following genera: Lachnospiraceae_ND 2004 group, Faecalitalea, Fusobacterium, Catenibacterium, Roseburia, Atopobium, Cloacibacillus, Clostridium innococum group, Ruminococcus torques group. All groups showed a low diversity of taxa with a predominance of opportunistic flora, including participants in oncogenesis. Conclusion. The results of the study show that patients with CP of various etiologies and patients with severe EPI who underwent specific intervention on the pancreas have intestinal microbiota dysbiosis, the severity of which is significantly influenced by the degree of EPI.
引用
收藏
页码:130 / 139
页数:10
相关论文
共 50 条
  • [31] Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis
    vanElburg, RM
    Uil, JJ
    vanAalderen, WMC
    Mulder, CJJ
    Heymans, HSA
    PEDIATRIC RESEARCH, 1996, 39 (06) : 985 - 991
  • [32] PHARMACOECONOMIC ANALYSIS OF DIFFERENT STRATEGIES OF REPLACEMENT THERAPY IN RUSSIAN PATIENTS WITH PANCREATIC EXOCRINE INSUFFICIENCY
    Ryazhenov, V. V.
    Maximkin, S. A.
    VALUE IN HEALTH, 2015, 18 (07) : A624 - A624
  • [33] Low prevalence of exocrine pancreatic insufficiency in patients with diabetes mellitus
    Vujasinovic, Miroslav
    Zaletel, Jelka
    Tepes, Bojan
    Popic, Betka
    Makuc, Jana
    Lenart, Metka Epsek
    Predikaka, Marjana
    Rudolf, Sasa
    PANCREATOLOGY, 2013, 13 (04) : 343 - 346
  • [34] Incidence of Pancreatic Exocrine Insufficiency in Patients Undergoing Liver Transplantation
    Klein, J.
    Rangel, M.
    Ifearulundu, I.
    Gely, Y.
    Spigel, Z.
    Janardhan, S.
    Hertl, M.
    Chan, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 574 - 575
  • [35] FACTORS ASSOCIATED WITH EXOCRINE PANCREATIC INSUFFICIENCY IN PATIENTS WITH CONGENITAL HYPERINSULINISM
    Wood, Phoebe
    Sanchez, Lucia
    Brownell, Jefferson N.
    Mitteer, Lauren
    De Leon-Crutchlow, Diva
    Lord, Katherine
    Sigal, Winnie
    Boyajian, Linda
    McKnight, Heather
    Stewart, Nicole
    Evans, Jordan
    Adzick, Scott
    Maqbool, Asim
    GASTROENTEROLOGY, 2023, 164 (06) : S848 - S848
  • [36] Study of Serum Pancreolauryl Test in Patients with Exocrine Pancreatic Insufficiency
    Tiscornia, Osvaldo
    Lopez Mingorance, Fabiana Norma
    Otero, Graciela
    Waisman, Hipolito
    del Carmen Maselli, Maria
    Monica Yapur, Viviana
    Di Carlo, Maria
    Tiscornia-Wasserman, Patricia Graciela
    Alberto Negri, Gustavo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S83 - S83
  • [37] Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia
    Panzuto, Francesco
    Magi, Ludovica
    Rinzivillo, Maria
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (04) : 383 - 386
  • [38] Pancreatic exocrine insufficiency occurs in most patients following pancreaticoduodenectomy
    Kumar, Thogari K.
    Tewari, Mallika
    Shukla, S. K.
    Mishra, S. P.
    INDIAN JOURNAL OF CANCER, 2021, 58 (04) : 511 - 517
  • [39] Exocrine pancreatic insufficiency and causes of abdominal symptoms in diabetes patients
    Kadaj-Lipka, Roland
    Rydzewska, Grazyna
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2020, 15 (04): : 289 - 293
  • [40] MONITORING THE EFFECT OF SUBSTITUTION THERAPY IN PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY
    JORGENSEN, BB
    PEDERSEN, NT
    WORNING, H
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1991, 26 (03) : 321 - 326